Global Biosimulation Market : Company Profiles and Forecast 2015 - 2021

Press Release   •   Jan 29, 2016 12:42 IST

Jan., 29, 2016, Mumbai, India: Market Reports on China presents the report, on “Global Biosimulation Market : Company Profiles and Forecast 2015 - 2021”. The market of Biosimulation market is segmented on the basis of products, end user, application, drug development.

Biosimulation is explained as a computer-aided mathematical simulation of biological processes and systems and hence is an integral part of systems biology. The main aim of Biosimulation is model-based prediction of the behavior and the dynamics of biological systems e.g. the response of an organ or a single cell towards a chemical. It is a predictive tool and used in discovery stage to determine the future outcomes of current experimental trials. 

The demand for Biosimulation market is expected to increase in forecasted period due to increase in the factors such as use of personalized medicine.

Factors that are driving the market are: Increase in the use of personalized medicine also continuous research and development is going on in the field which has led to the improvement and simulation of modeling tools, also the growth in the biotechnological and pharmaceutical industries has helped Biosimulation industry to grow. Also, the industry is expecting growth due to the boom in drugs market as a result of increase in ageing population and increasing number of chronic diseases. Some of the factors which are restraining the market are shortage of skilled professionals, higher cost of the process, lack of standardized tools and applications and limited knowledge about biological process.

The market of Biosimulation market is segmented on the basis of products, end user, application, drug development. Geographically the market is divided in to North America (US, Canada), Europe (UK, Italy, Spain, France, Germany, rest of Europe), Asia-Pacific (India, Japan, Australia, China, Korea, Rest of Asia Pacific) and Rest of World (Latin America, MENA and Africa). The key providers of biosimulation technology are Certara, Biovia, Dassault Systmes.

This Research Report covers

1. Historical data

2.Revenue forecasts, growth rates and CAGR up to 2021

3.Industry Analysis

4.Competitive Analysis

5. Key geographic growth data

Table of Contents

1. Introduction

1.1 Executive Summary

1.2 Estimation methodology

2. Market overview

2.1 Market definition and scope

2.2 Key findings

2.3 Parametric analysis

2.3.1 Personalized medicine market

2.3.2 Investment in R&D by various organizations

3. Market determinants

3.1 Market driver

3.1.1 Increased use of personalized medicine

3.1.2 Research and development in the field

3.1.3 Growth in pharmaceutical and biotechnological industries.

3.1.4 Advent of improved simulation and modeling tools

To view a full Executive Summary and Table of Contents, please visit:

Related Reports:

About Author Bio: Sarah Davis is working with MarketReportsonChina which is a portal where you can access thousands of reports on China starting from Aeronautics to Zinc (A-Z). The website provides market reports on different sectors.

Contact Us
Market Reports on China
Contact No: India: +91.22.27810773